NDC 33342-0150-53
IBANDRONATE SODIUM 150 mg/1 TABLET, FILM COATED
Available — 2-Day Shipping
NDC
33342-0150-53
Generic Name
IBANDRONATE SODIUM
Brand Name
IBANDRONATE SODIUM
Strength
150 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Package Size
—
Labeler
Macleods Pharmaceuticals Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS & USAGE Ibandronate sodium is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis. ( 1.1 ). Limitations of Use The optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use. ( 1.2 ) 1.1 Treatment and Prevention of Postmenopausal Osteoporosis Ibandronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. Iban…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All IBANDRONATE SODIUM Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other IBANDRONATE SODIUM NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 33342-0150-53 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).